338results about How to "High acceptability" patented technology

There is proposed a network access authentication and authorization mechanism in which an authentication session in an authentication, authorization and accounting procedure for a user equipment for providing an initial network access is executed. A first identification element related to the user equipment is obtained. Then, a user credential validation procedure is performed wherein a second identification element related to the user equipment or related to a user of the user equipment is obtained. The obtained first and second identification elements are processed for determining whether a match between the first and second identification elements exists. In addition, the authentication session executed for the user equipment is identified on the basis of the result of the processing of the first and second identification elements. Then, a change of an authorization of the user equipment is executed for providing a modified network access.

Dairy or non-diary based fortified carbonated beverage solutions that supply essential nutrients in the human diet. The solution contains per 354 ml, calcium, magnesium and potassium ions in the form of salts and optionally vitamins A, D, C, lutein, zeaxanthin and folic acid in specified amounts to provide dietary supplementation. Sweeteners, stabilizers, flavors and carbonation can also be added to enhance flavor, taste, mouth-feel, ingredient solubilization and product appearance. A method of making the beverages is also described. A method of using carbonation to reduce bacterial counts and reduce degradation of essential nutrients in milk-based beverages with or without pasteurization is also disclosed.

A self-healing cement system includes cement, water and at least one additive that swells in contact with water from reservoir or from formation in the case of a structural failure in the set cement to provide a physical barrier in the zone of failure. Examples of such material include particles of super-absorbent polymer. These additives have the effect of making the cement self-healing in the event of physical failure or damage such as micro-annuli. The self healing property is produced by the contact of the water itself, the potential repair mechanism is thus activated if and when needed in case of start of loss of zonal isolation. Several super-absorbent polymers have been identified such as polyacrylamide, modified crosslinked poly(meth)acrylate and non-solute acrylic polymers.

A method for producing an aqueous polyimide precursor solution composition, including reacting a tetracarboxylic dianhydride and a diamine, which has a solubility in water at 25° C. of 0.1 g/L or more, in the presence of an imidazole, using water as a reaction solvent to provide an aqueous polyimide precursor solution composition.

Hypotonic formulations were evaluated for delivering water-soluble drugs and for drug delivery with muco-inert (that is, non-adhesive) mucus-penetrating nanoparticles (MPP). Hypotonic formulations markedly increased the rate at which drugs and MPP reached the epithelial surface, including deep into the vaginal folds. Minimally hypotonic formulations, preferably ranging from 20-220 mOsm/kg, provided rapid and uniform delivery of MPP to the entire vaginal surface, with minimal risk of epithelial toxicity. Data also show that there is a higher osmolality in the colon, such that vehicles with an osmolality above that of blood plasma (generally considered isotonic at ˜300 mOsm/kg), still lead to improvements in distribution in the colon due to rapid, osmotically-induced fluid absorption. The range for improved colon distribution with a hypotonic vehicle in the colon is ˜20 mOsm/kg-450 mOsm/kg.

Sprayable, anhydrous and physically/chemically stable dermatological/pharmaceutical compositions, well suited for the treatment of a variety of dermatological disorders, notably psoriasis, contain: a) a therapeutically effective amount of a solubilized corticord; notably clobetasol propionate; b) a therapeutically effective amount of a solubilized vitamin D derivative, notably calcitriol; c) an alcohol phase; d) at least one volatile silicone; and e) a non-volatile oily phase which comprises one or more oils; formulated into f), a sprayable and topically applicable, dermatologically/pharmaceutically acceptable vehicle therefor.

Disclosed are liquid nutritional compositions comprising: carbohydrate; lipid having from about 0.1% to about 20% of an n-3 polyunsaturated fatty acid, n-6 polyunsaturated fatty acid, or combinations thereof by weight of the composition; a protein matrix having from about 15% to about 50% of a whey protein fraction by weight of the total protein in the composition; and a limonene-containing material, cranberry oil, or combinations thereof. The compositions are preferably aseptically packaged, and provide enhanced oxidative stability, flavor, and aroma, especially when formulated with relative high polyunsaturated fatty acid concentrations.

The present invention relates to compounds of phosphonic acid-containing T3 mimetics and monoesters thereof, stereoisomers, pharmaceutically acceptable salts, co-crystals, and prodrugs thereof and pharmaceutically acceptable salts and co-crystals of the prodrugs, as well as their preparation and uses for preventing and/or treating metabolic diseases such as obesity, NASH, hypercholesterolemia and hyperlipidemia, as well as associated conditions such as atherosclerosis, coronary heart disease, impaired glucose tolerance, metabolic syndrome x and diabetes.

The lens presents horizontal prismatic refractive power that varies progressively along the main progression meridian (MM′) with the addition of horizontal prismatic power being greater than 2 prismatic diopters in absolute value, this addition of horizontal prismatic power being defined by the difference between the horizontal prismatic refractive power at the reference point (L) of the far vision zone and the horizontal prismatic refractive power at the projection point (P′) of the reference point (P) of the near vision zone (VP) on the vertical line passing through the reference point (L) of the far vision zone.

Novel 2′-C-methyl nucleoside 5′-monophosphate and 4′-C-methyl nucleoside 5′-monophosphate derivatives, stereoisomers, and pharmaceutically acceptable salts or prodrugs thereof, their preparation, and their uses for the treatment of hepatitis C viral infection are described.

A system for transdermal delivery of norelgestromin (NGMN) to an individual. The system has a high NGMN loading with suitable permeation enhancers to effect therapeutic flux rate. Polyacrylate drug reservoir with the NGMN and high loading of one or more of permeation enhancers and NGMN dissolved therein provides desirable adhesive characteristics and effective transdermal therapeutic properties. Estrogen can be delivered with the NGMN.

The present invention provides a lead-acid battery superior in high-efficiency charging characteristic to conventional lead-acid batteries; and a carbon material used in the lead-acid battery, having excellent charge acceptability. That is, the present invention provides a lead-acid battery which uses, as an additive to the anode active material, a simple substance and/or a compound thereof, both having a catalysis for desulfurization or a catalysis for SOX oxidation by adding to or loading on a carbon material such as active carbon, carbon black or the like and thereby has superior high-efficiency charging characteristic and improved charging acceptability. When such a lead-acid battery whose anode contains a carbon material containing or loading thereon the above simple substance and/or compound, is applied to electric cars, various hybrid cars, power storage systems, elevators, electromotive tools and power source systems such as uninterruptible power source, distributed power source and the like, all having high input and output requirements, stable control can be obtained.

A battery includes a positive electrode, a negative electrode, and an electrolyte. At least one of the positive electrode and the negative electrode is an electrode containing an active material and an inorganic oxide. The inorganic oxide is in a state of being extractable with tetrahydrofuran or methyl ethyl ketone at normal temperature.

Compounds of Formula I, stereoisomers, and pharmaceutically acceptable salts or prodrugs thereof, their preparation, and their uses for the treatment of hepatitis C viral infection are described: